Antivirals

Antiviral medications are drugs used to treat viral infections in humans. These drugs work by either inhibiting the virus's ability to replicate inside the host cells or by blocking the virus from entering the host cells. While antibiotics are widely used for bacterial infections, antivirals are specifically designed to target viruses and are hence crucial in treating viral infections. With the recent outbreak of coronavirus disease (COVID-19), research into antivirals has become increasingly important. Specifically, there has been a focus on developing antivirals that are effective against coronaviruses. Currently, there are a few antivirals that are being used to treat COVID-19 patients, including remdesivir and favipiravir. These drugs have been found to help reduce the severity and duration of symptoms, although their efficacy is still being studied. Antivirals are also important for the prevention of viral infections. For example, for individuals at high risk for contracting HIV, pre-exposure prophylaxis (PrEP) with antivirals has been shown to be effective in preventing HIV transmission. While antivirals have been a crucial component in the fight against viral infections, it is important to note that viruses can develop resistance to these drugs over time. Therefore, ongoing research into the development of new and better antivirals is critical to ensure that we are able to effectively combat viral infections.

Related Articles

2 journal(s) found

Clinical Research In HIV AIDS And Prevention

ISSN: 2324-7339
Type: Open Access Journal
Editor-in-Chief: Dr Shivaji Kashinath Jadhav, Department of Molecular Oncology Lilac Insights Pvt. Ltd.
HIV is a virus that gradually attacks the immune system, which is our body's natural defense against illness. If a person becomes infected with HIV, they will find it harder to fight off infections and diseases. The virus destroys white blood cell and makes copies of itself inside them. Infected may carry various different strains in their body.

International Journal of Sexually Transmitted Diseases

ISSN: 2994-6743
Type: Open Access Journal
Editor: Bassem Refaat, Laboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University
International Journal of Sexually Transmitted Diseases is an advanced, broad – based, open access, peer reviewed journal. The goal is to provide more resourceful information in this era for all scientists and researchers, as well as in-depth knowledge, advanced techniques in the prevention, diagnosis and treatment